“Detection of SV40 like viral DNA and viral antigens in malignant pleural mesothelioma.” M. Ramael, J. Nagels, H. Heylen, S. De Schepper, J. Paulussen, M. De Maeyer and C. Van Haesendonck. Eur Respir J 1999; 14: 1381–1386.
Source: Eur Respir J, 55 (5) 9951381; 10.1183/13993003.51381-1999 Disease area: Respiratory infections, Thoracic oncologyRating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
“Detection of SV40 like viral DNA and viral antigens in malignant pleural mesothelioma.” M. Ramael, J. Nagels, H. Heylen, S. De Schepper, J. Paulussen, M. De Maeyer and C. Van Haesendonck. Eur Respir J 1999; 14: 1381–1386.. Eur Respir J, 55 (5) 9951381; 10.1183/13993003.51381-1999
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
“Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis.” M. Wilschanski, L.L. Miller, D. Shoseyov, H. Blau, J. Rivlin, M. Aviram, M. Cohen, S. Armoni, Y. Yaakov, T. Pugatch, M. Cohen-Cymberknoh, N.L. Miller, A. Reha, V.J. Northcutt, S. Hirawat, K. Donnelly, G.L. Elfring, T. Ajayi and E. Kerem. Eur Respir J 2011; 38: 59–69. Source: Eur Respir J 2011; 38: 996 Year: 2011
“Mast cells promote lung vascular remodelling in pulmonary hypertension.” J. Hoffmann, J. Yin, M. Kukucka, N. Yin, I. Saarikko, A. Sterner-Kock, H. Fujii, H. Leong-Poi, H. Kuppe, R.T. Schermuly and W.M. Kuebler. Eur Respir J 2011; 37: 1400–1410. Source: Eur Respir J 2012; 40: 515-517 Year: 2012
"No evidence for interstitial lung oedema by extensive pulmonary function testing at 4,559". C. Dehnert, A.M. Luks, G. Schendler, E. Menold, M.M. Berger, H. Mairbäurl, V. Faoro, D.M. Bailey, C. Castell, G. Hahn, P. Vock, E.R. Swenson and P. Bärtsch. Eur Respir J 2010; 35: 812-820. Source: Eur Respir J 2010; 36: 699 Year: 2010
“Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias.” M. Okamoto, T. Hoshino, Y. Kitasato, Y. Sakazaki, T. Kawayama, K. Fujimoto, K. Ohshima, H. Shiraishi, M. Uchida, J. Ono, S. Ohta, S. Kato, K. Izuhara and H. Aizawa. Eur Respir J 2011; 37: 1119–1127. Source: Eur Respir J 2014; 44: 826 Year: 2014
Author Correction: “Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis.” M. Sester, G. Sotgiu, C. Lange, C. Giehl, E. Girardi, G.B. Migliori, A. Bossink, K. Dheda, R. Diel, J. Dominguez, M. Lipman, J. Nemeth, P. Ravn, S. Winkler, E. Huitric, A. Sandgren and D. Manissero. Eur Respir J 2011; 37: 100–111. Source: Eur Respir J 2012; 39: 793 Year: 2012
Author Correction: “Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-?B and EGFR pathways.” C.A. Hewson, J.J. Haas, N.W. Bartlett, S.D. Message, V. Laza-Stanca, T. Kebadze, G. Caramori, J. Zhu, M.R. Edbrooke, L.A. Stanciu, O.M. Kon, A. Papi, P.K. Jeffery, M.R. Edwards and S.L. Johnston. Eur Respir J 2010; 36: 1425–1435. Source: Eur Respir J 2012; 39: 793 Year: 2012
Author Correction: “Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis.” R. Diel, D. Goletti, G. Ferrara, G. Bothamley, D. Cirillo, B. Kampmann, C. Lange, M. Losi, R. Markova, G.B. Migliori, A. Nienhaus, M. Ruhwald, D. Wagner, J.P. Zellweger, E. Huitric, A. Sandgren and D. Manissero. Eur Respir J 2011; 37: 88–99. Source: Eur Respir J 2012; 39: 793 Year: 2012
“Cellular mechanisms underlying steroid-resistant asthma.” Ridhima Wadhwa, Kamal Dua, Ian M. Adcock, Jay C. Horvat, Richard Y. Kim and Philip M. Hansbro. Eur Respir Rev 2019; 28: 190021. Source: Eur Respir Rev, 28 (154) 195096; 10.1183/16000617.5096-2019 Year: 2019
“Effect of different asthma treatments on risk of cold-related exacerbations.” H.K. Reddel, C. Jenkins, S. Quirce, M.R. Sears, E.D. Bateman, P.M. O'Byrne, M. Humbert, R. Buhl, T. Harrison, G.G. Brusselle, A. Thorén, U. Sjöbring, S. Peterson, O. Östlund and G.S. Eriksson. Eur Respir J 2011; 38: 584–593. Source: Eur Respir J 2012; 39: 1280 Year: 2012
COX-2 expression during early lung squamous cell carcinoma oncogenesis. C. Mascaux, B. Martin, J-M. Verdebout, V. Ninane and J-P. Sculier. Eur Respir J 2005; 26: 198-203. Source: Eur Respir J 2005; 26: 753 Year: 2005
“Triple therapy in idiopathic pulmonary fibrosis: an alarming press release.” A.U. Wells, J. Behr, U. Costabel, V. Cottin and V. Poletti. Eur Respir J 2012; 39: 805–806. Source: Eur Respir J 2012; 39: 1552 Year: 2012
“Sleep apnoea is associated with major cardiac events in peripheral arterial disease.” Karri T. Utriainen, Juhani K. Airaksinen, Olli Polo, Ruut Laitio, Mikko J. Pietilä, Harry Scheinin, Tero Vahlberg, Kari A. Leino, Erkki S. Kentala, Jouko R. Jalonen, Harri Hakovirta, Riitta Parkkola, Sami Virtanen and Timo T. Laitio. Eur Respir J 2014; 43: 1652-1660. Source: Eur Respir J, 51 (4) 1351309; 10.1183/13993003.51309-2013 Year: 2018
“Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis.” Yael Gernez, Jeffrey Waters, Bojana Mirkovic, Gillian M. Lavelle, Colleen E. Dunn, Zoe A. Davies, Cassie Everson, Rabindra Tirouvanziam, Elana Silver, Sylvan Wallenstein, Sanjay H. Chotirmall, Noel G. McElvaney, Leonore A. Herzenberg and Richard B. Moss. Eur Respir J 2016; 47: 177–185. Source: Eur Respir J 2016; 47:1892 Year: 2016
“Prolonged shedding of rhinovirus and re-infection in adults with respiratory tract illness.” Kalina T. Zlateva, Jutte J.C. de Vries, Frank E.J. Coenjaerts, Anton M. van Loon, Theo Verheij, Paul Little, Christopher C. Butler, Herman Goossens, Margareta Ieven and Eric C.J. Claas on behalf of the GRACE Study Group. Eur Respir J 2014; 44: 169–177. Source: Eur Respir J 2014; 44: 556 Year: 2014
“Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.” Michael Kreuter, Marlies S. Wijsenbeek, Martina Vasakova, Paolo Spagnolo, Martin Kolb, Ulrich Costabel, Derek Weycker, Klaus-Uwe Kirchgaessler and Toby M. Maher. Eur Respir J 2016; 47: 1776–1784. Source: Eur Respir J 2016; 48: 593 Year: 2016
“Malignant pleural effusion: from bench to bedside.” Ioannis Psallidas, Ioannis Kalomenidis, Jose M. Porcel, Bruce W. Robinson and Georgios T. Stathopoulos. Eur Respir Rev 2016; 25: 189–198. Source: Eur Respir Rev 2016; 25: 360 Year: 2016
“Guidelines for the management of work-related asthma.” X. Baur, T. Sigsgaard, T.B. Aasen, P.S. Burge, D. Heederik, P. Henneberger, P. Maestrelli, J. Rooyackers, V. Schlünssen, O. Vandenplas and D. Wilken on behalf of the ERS Task Force on the Management of Work-related Asthma. Eur Respir J 2012; 39: 529–545. Source: Eur Respir J 2012; 39: 1553 Year: 2012
“Characterisation of patients with interstitial pneumonia with autoimmune features.” Justin M. Oldham, Ayodeji Adegunsoye, Eleanor Valenzi, Cathryn Lee, Leah Witt, Lena Chen, Aliya N. Husain, Steven Montner, Jonathan H. Chung, Vincent Cottin, Aryeh Fischer, Imre Noth, Rekha Vij and Mary E. Strek. Eur Respir J 2016; 47: 1767–1775. Source: Eur Respir J, 49 (5) 1551565; 10.1183/13993003.51565-2015 Year: 2017
“Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes.” Sabina A. Guler, Joanne M. Kwan, Janice M. Leung, Nasreen Khalil, Pearce G. Wilcox and Christopher J. Ryerson. Eur Respir J 2020; 55: 1900647. Source: Eur Respir J, 55 (3) 1950647; 10.1183/13993003.50647-2019 Year: 2020
“Global strategy for asthma management and prevention: GINA executive summary.” E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet, J.M. Drazen, J.M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S.E. Pedersen, E. Pizzichini, S.D. Sullivan, S.E. Wenzel and H.J. Zar. Eur Respir J 2008; 31: 143–178. Source: Eur Respir J, 51 (2) 0751387; 10.1183/13993003.51387-2007 Year: 2018